March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Circadien Cycle And Chronic Idiopathic Central Serous Chorioretinopathy Treated With Low Dose Verteporfin
Author Affiliations & Notes
  • Elodie Setrouk
    Ophthalmology, Hospital Robert Debre, Reims, France
  • Tony Garcia
    Ophthalmology, Hospital Robert Debre, Reims, France
  • Alain Ducasse
    Ophthalmology, Hospital Robert Debre, Reims, France
  • carl Arndt
    Ophthalmology, Hospital Robert Debre, Reims, France
  • Footnotes
    Commercial Relationships  Elodie Setrouk, None; Tony Garcia, None; Alain Ducasse, None; carl Arndt, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 975. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Elodie Setrouk, Tony Garcia, Alain Ducasse, carl Arndt; Circadien Cycle And Chronic Idiopathic Central Serous Chorioretinopathy Treated With Low Dose Verteporfin. Invest. Ophthalmol. Vis. Sci. 2012;53(14):975.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Chronic Central Serous Chorioretinopathie(CRSC) is a multifocal disease. Photodynamic therapy(PDT)with vertepofin (3mg/m2) is a symptomatic treatment. A further reduction to 1,5mg/m2 could reduce potential side and thus improve safety of this off label treatment. The present study was designed to evaluate circadian disturbance and corticosteroid in patients treated with chronic CRSC in an ongoing trial comparing the effect of 3mg/m2 verteporfin with 1,5mg/m2.

Methods: : In all patients with chronic CRSC between 01/01/2009 to 11/31/2011, a history of corticosteroid treatment, sleep disturbance and irregular working hours was noted. If visual acuity was less than 20/40 for more than three months without any tendency of improvement,PDT was performed. The patients were randomly assigned to either treatment group,3mg/m2 or 1,5mg/m2. A mesure of visual acuity, an optical coherence tomography (OCT), angiography(fluorescein and indocyanine green) was performed at baseline, with evaluation at 12 months.

Results: : During the period of inclusion,43 patients were examined, 19 were trated with PDT. 11 patients completed a follow-up of 12 months, 3 patients (27%) had a history of corticosteroid, 5 patients (45%) had sleep disturbances and 6 (54%) worked at night.On case of improvement of visual acuity >5 ETDRS letters was observed in group 1 against 2 in group 2. The macular thickness was reduced > 100 microns in two patients in group 2,no such improvement were observed in group 1.

Conclusions: : On this preliminary study of photodynamic therapy with chonic CRSC, functional and morphological improvement is inconstant. It is likely that other factors such as existance of a corticosteroid treatment or a disruption of the circadian cycle is involved in the spontaneous evolution or the reponse to treatment.

Keywords: retinochoroiditis • melatonin • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×